Controlled Synthesis of Mesoporous π-Conjugated Polymer Nanoarchitectures as Anodes for Lithium-Ion Batteries.
Limin ShiWenda LiYong WuFacai WeiTingting ZhangJianwei FuChengbin JingJiangong ChengShaohua LiuPublished in: Macromolecular rapid communications (2022)
Conjugated polymers possess better electron conductivity due to large π-electron conjugated configuration endowing them significant scientific and technological interest. However, the obvious deficiency of active-site underutilization impairs their electrochemical performance. Therefore, designing and engineering π-conjugated polymers with rich redox functional groups and mesoporous architectures could offer new opportunities for them in these emerging applications and further expand their application scopes. Herein, a series of 1,3,5-tris(4-aminophenyl) benzene (TAPB)-based π-conjugated mesoporous polymers (π-CMPs) are constructed by one-pot emulsion-induced interface assembly strategy. Furthermore, co-induced in situ polymerization on 2D interfaces by emulsion and micelles is explored, which delivers sandwiched 2D mesoporous π-CMPs-coated graphene oxides (GO@mPTAPB). Benefiting from specific redox-active functional groups, excellent electron conductivity and a 2D mesoporous conjugated framework, GO@mPTAPB exhibits high capability of accommodating Li + anions (up to 382 mAh g -1 at 0.2 A g -1 ) and outstanding electrochemical stability (87.6% capacity retention after 1000 cycles). The ex situ Raman and impedance spectra are further applied to reveal the high reversibility of GO@mPTAPB. This work will greatly promote the development of advanced π-CMPs-based organic anodes toward energy storage devices.
Keyphrases
- photodynamic therapy
- ionic liquid
- high glucose
- gold nanoparticles
- highly efficient
- metal organic framework
- diabetic rats
- drug delivery
- ion batteries
- genome wide
- label free
- endothelial cells
- drug induced
- density functional theory
- single cell
- wastewater treatment
- cancer therapy
- mass spectrometry
- molecular dynamics
- drug release
- replacement therapy
- walled carbon nanotubes